CIC
USNA icon

Cornercap Investment Counsel’s Usana Health Sciences USNA Stock Holding History

Cornercap Investment Counsel’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,413
Closed -$471K – 637
2024
Q2 		$471K Sell
10,413
-91
-0.9% -$4.19K 0.08% 479
2024
Q1 		$509K Hold
10,504
– – 0.08% 447
2023
Q4 		$563K Buy
+10,504
New +$531K 0.09% 381
2023
Q1 		– Sell
-16,153
Closed -$859K – 654
2022
Q4 		$859K Buy
16,153
+1,748
+12% +$94.7K 0.15% 302
2022
Q3 		$807K Sell
14,405
-97
-0.7% -$6.41K 0.15% 290
2022
Q2 		$1.05M Hold
14,502
– – 0.18% 188
2022
Q1 		$1.15M Buy
14,502
+1,632
+13% +$147K 0.13% 235
2021
Q4 		$1.3M Sell
12,870
-1,476
-10% -$147K 0.19% 150
2021
Q3 		$1.32M Buy
14,346
+126
+0.9% +$12.1K 0.15% 173
2021
Q2 		$1.46M Sell
14,220
-34
-0.2% -$3.41K 0.16% 152
2021
Q1 		$1.39M Buy
+14,254
New +$1.3M 0.16% 174
2020
Q4 		– Sell
-12,094
Closed -$891K – 606
2020
Q3 		$891K Buy
+12,094
New +$970K 0.13% 250
2019
Q3 		– Sell
-9,405
Closed -$747K – 462
2019
Q2 		$747K Sell
9,405
-105
-1% -$8.33K 0.1% 352
2019
Q1 		$798K Buy
9,510
+1,035
+12% +$108K 0.11% 337
2018
Q4 		$998K Buy
+8,475
New +$980K 0.15% 179
2018
Q2 		– Sell
-24,535
Closed -$2.11M – 459
2018
Q1 		$2.11M Sell
24,535
-455
-2% -$35.2K 0.3% 98
2017
Q4 		$1.85M Buy
24,990
+13,465
+117% +$901K 0.25% 115
2017
Q3 		$665K Buy
11,525
+2,175
+23% +$128K 0.09% 334
2017
Q2 		$599K Hold
9,350
– – 0.1% 231
2017
Q1 		$539K Sell
9,350
-30
-0.3% -$1.79K 0.09% 286
2016
Q4 		$574K Buy
9,380
+560
+6% +$36.5K 0.1% 260
2016
Q3 		$610K Buy
+8,820
New +$582K 0.11% 205
2015
Q3 		– Sell
-9,040
Closed -$618K – 399
2015
Q2 		$618K Hold
9,040
– – 0.11% 101
2015
Q1 		$502K Buy
+9,040
New +$463K 0.09% 127

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Cornercap Investment Counsel's USNA Position: Q3 2024 in Review

Cornercap Investment Counsel sold out of Usana Health Sciences (USNA) in Q3 2024, closing a stake of 10,413 shares — an estimated $471K sold.

Cornercap Investment Counsel first reported a position in USNA in Q1 2015 and held it in 24 quarters. The position peaked at $2.11M in Q1 2018. 147 funds tracked by Wall St. Rank hold USNA as of Q3 2024.

  • Cornercap Investment Counsel reported no remaining Usana Health Sciences position as of Q3 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 10,413 Usana Health Sciences shares in Q3 2024, an estimated $471K.
  • Cornercap Investment Counsel first reported a position in Usana Health Sciences in Q1 2015 and held it in 24 quarters.
  • Cornercap Investment Counsel's Usana Health Sciences position peaked at $2.11M in Q1 2018.
  • 147 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2024.

Based on Cornercap Investment Counsel's 13F filing for Q3 2024, filed 6 Nov 2024.